HCV Seroconversion in two Egyptian Hemodialysis Units: Role of Detection Method and Patients Isolation

Mohamed Elâ€“Tayeb Nasser; Khaled Mohamed Younes; Dawlat Hussein Sany; Samar Samir Youssef; Mohamed Mahmoud; Bassim Samy El-Sayed

doi:10.3889/oamjms.2014.022

Authors

Mohamed Elâ€“Tayeb Nasser Internal Medicine & Nephrology Department, Faculty of Medicine, Ain Shams University, Doki-Eltahrir St., Cairo 12311
Khaled Mohamed Younes Internal Medicine Department, Medical Division, National Research Center, Doki-Eltahrir St., Cairo 12311
Dawlat Hussein Sany Internal Medicine & Nephrology Department, Faculty of Medicine, Ain Shams University, Doki-Eltahrir St., Cairo 12311
Samar Samir Youssef Microbial Biotechnology Department, Genetic Engineering and Biotechnology Division, National Research Center, Doki-Eltahrir St., Cairo 12311
Mohamed Mahmoud Internal Medicine Department, Medical Division, National Research Center, Doki-Eltahrir St., Cairo 12311
Bassim Samy El-Sayed Internal Medicine Department, Medical Division, National Research Center, Doki-Eltahrir St., Cairo 12311

DOI:

https://doi.org/10.3889/oamjms.2014.022

Keywords:

End stage renal disease, Hepatitis c virus, seroconversion, polymerase chain reaction, ELISA.

Abstract

Background: Hepatitis C virus (HCV) infection is a significant cause of morbidity and mortality in end stage renal disease (ESRD) patients on hemodialysis (HD).Â Routine HCV viremia screening is recommended in those patients but it is not applied.

Aim: To evaluate the seroconversion rate in HD patients based on viremia detection compared to antibody (Ab), and to assess the role of isolation on the rate of seroconversion in those patients.

Materials and Methods: One hundred ESRD patients from two HD units using same infection control criteria were enrolled in the study; only one unit was applying isolation for HCV patients. Patients were followed up for 12 month; HCV positivity was tested at the begining of the study and after 12 month of HD. HCV Ab and viremia were detected by third generation ELISA and PCR respectively.

Results: The seroconversion rate was 0% based on HCV Ab detection by ELISA, compared with the 16 % seroconversion rate based on viremia detection by PCR. Notably, viremia seroconversion was seen only in the HD unit lacking the isolation system.

Conclusion: HCV screening in HD units should be based on viremia detection; isolation in HD units prevents HCV spreading.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004; 44:20â€“9.

El-Zanaty F, Way A: Egypt Demographic and Health Survey 2008. Egyptian:Ministry of Health. Cairo: El-Zanaty and Associates, and Macro International, 2009.

Paez Jimenez A, Mohamed MK, Sharaf Eldin N, et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PloS One. 2009; 4:e7193.

Paez Jimenez A, Sharaf Eldin N, Rimlinger F, et al. HCV iatrogenic and intrafamilial transmission in greater Cairo, Egypt. Gut. 2010; 59:1554â€“60.

Yuqiang, C.; Wang, N.; Sheng, X., et al.: Hepatitis C virus infection in uremic patients on maintenance hemodialysis. Afric J Microb Res. 2011; 22: 3677-83.

Khan, S., Attaullah, A., Ijaz, A., et al. Rising burden of Hepatitis C Virus in hemodialysis patients. J Virol. 2011;8: 438.

Egyptian Renal Registry: 2008 report, ESNT congress, Hurghada Egypt, February, 2009.

Nicolardi E, Grieco A, Rapaccini GL, Pompili M: [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients]. G Ital Nefrol. 2010; 27(3):262-73.

Tu AW, Buxton JA, Whitlock M.: Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol. 2009; 20(2):e19-23.

Sun J, Yu R, Zhu B, Wu J, Larsen S, Zhao W: Hepatitis C infection and related factors in hemodialysis patients in China: systematic review and meta-analysis. Ren Fail. 2009; 31(7):610-20.

Natov SN, Pereira BJ: Hepatitis C virus in chronic dialysis patients. Minerva Urol Nefrol. 2005; 57(3):175-97.

Izopet J, Sandres-SaunÃ© K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005; 77: 70-76.

Taskapan H, Oymak O, Dogukan A, Utas C. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol. 2001; 55: 477-48.

Marchesi D, Aric I, and Poletti E. Outbreak of HCV infection in hemodialysis patients. Nephrology Dialysis Transplantation. 1998; 13, 795â€“799.

Yang CS, Chang HH, Chou CC, Peng SJ.: Isolation effectively prevents the transmission of HCV in the hemodialysis units. J Formos Med. Assoc. 2003; 102:79-85.

Liu CH. and Kao JH. Treatment of hepatitis C virus infection in patients with end-stage renal disease. J Gastroent. and Hepat. 2011; 26: 228â€“239.

Muerhoff AS, Jiang L, Shah DO, Gutierrez RA, Patel J, Garolis C, Kyrk CR, Leckie G, Frank A, Stewart JL, Dawson GJ. Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay. Transfusion. 2002; 42: 349-356.

Youssef SS, Nasr AS, El Zanaty T, El Rawi RS, Mattar MM. Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders.Hepat Res Treat. 2012; 2012:429784.

Alter, MJ. Prevention of spread of hepatitis C. Hepatology. 2002; 36(5 Suppl l):S93-8.

Moini M, Ziyaeyan M, Aghaei S, Sagheb MM, Taghavi SA, Moeini M, Jamalidoust M, Hamidpour L. Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction. Hepat Mon. 2013;13(6):e9147.

Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol. 2008;28(4):628-40.

El-Sherif A, Elbahrawy A, Aboelfotoh A, Abdelkarim M, Saied Mohammad AG, Abdallah AM, et al. High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis. Hemodial Int. 2012;16(3):420-7.

Schneeberger PM, Keur I, Van der Vliet W, et al. Hepatitis C virus infection in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol. 1998; 36:1171-1175.

Gallego E, Lopez A, Perez J et al., Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clinical Practice. 2006; 104: c1â€“c6.

Yang C S, Chang H H, Chou C C, and Peng S J. Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit. Journal of the Formosan Medical Association. 2003; 102: 79â€“85.

Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL. Prevention of hepatitis C virus in dialysis units. Nephron. 1995; 70: 301â€“306.

Shaheen F A, Huraib S O, Al-Rashed R et al. Prevalence of hepatitis C antibodies among hemodialysis patients in Jeddah area, Saudi Arabia. Saudi Medical Journals. 2003; 2: S125â€“S126.

Shebeb AM, Kotkat AM, Abd El Reheim SM, Farghaly AG, Fetohy EM. An intervention study for prevention of HCV infection in some hemodialysis units in alexandria. J Egypt Public Health Assoc. 2006; 81(1-2):119-41.

Soliman AR, Abd Elaziz M M, and El lawindi M I. Evaluation of an Isolation Program of Hepatitis C Virus Infected Hemodialysis Patients in Some Hemodialysis Centers in Egypt. ISRN Nephrology. 2013, Article ID 395467.

Yassin S, El Dib M and Roshd D. Nursesâ€™ Performance, isolation policy and HCV Sero-conversion among Hemodialysis Patients in Egyptian Hospitals. Life Science Journal. 2012;9(1):740-749.